RU2003105379A - METHOD FOR TREATING PATIENTS WITH CHRONIC HEPATITIS - Google Patents
METHOD FOR TREATING PATIENTS WITH CHRONIC HEPATITISInfo
- Publication number
- RU2003105379A RU2003105379A RU2003105379/14A RU2003105379A RU2003105379A RU 2003105379 A RU2003105379 A RU 2003105379A RU 2003105379/14 A RU2003105379/14 A RU 2003105379/14A RU 2003105379 A RU2003105379 A RU 2003105379A RU 2003105379 A RU2003105379 A RU 2003105379A
- Authority
- RU
- Russia
- Prior art keywords
- patient
- granocyte
- chronic hepatitis
- treating patients
- proliferation
- Prior art date
Links
- 206010008909 Chronic hepatitis Diseases 0.000 title claims 2
- 208000006454 Hepatitis Diseases 0.000 title claims 2
- 102100005499 PTPRC Human genes 0.000 claims 3
- 101700059076 PTPRC Proteins 0.000 claims 3
- 102100003279 CD38 Human genes 0.000 claims 2
- 101700044948 CD38 Proteins 0.000 claims 2
- 210000003494 Hepatocytes Anatomy 0.000 claims 2
- 238000001990 intravenous administration Methods 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 210000000130 stem cell Anatomy 0.000 claims 2
- 229960002170 Azathioprine Drugs 0.000 claims 1
- 210000004369 Blood Anatomy 0.000 claims 1
- 102100003268 CD14 Human genes 0.000 claims 1
- 101700027514 CD14 Proteins 0.000 claims 1
- 102100016492 CD34 Human genes 0.000 claims 1
- 108060001251 CD34 Proteins 0.000 claims 1
- 210000003714 Granulocytes Anatomy 0.000 claims 1
- 239000009456 Liv 52 Substances 0.000 claims 1
- 210000004185 Liver Anatomy 0.000 claims 1
- 210000000440 Neutrophils Anatomy 0.000 claims 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N Prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 claims 1
- SEBFKMXJBCUCAI-HKTJVKLFSA-N Silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 229960000070 antineoplastic Monoclonal antibodies Drugs 0.000 claims 1
- LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 230000004663 cell proliferation Effects 0.000 claims 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 claims 1
- 230000002443 hepatoprotective Effects 0.000 claims 1
- 230000001506 immunosuppresive Effects 0.000 claims 1
- 238000001802 infusion Methods 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 230000000527 lymphocytic Effects 0.000 claims 1
- 230000004089 microcirculation Effects 0.000 claims 1
- 229960000060 monoclonal antibodies Drugs 0.000 claims 1
- 102000005614 monoclonal antibodies Human genes 0.000 claims 1
- 108010045030 monoclonal antibodies Proteins 0.000 claims 1
- 239000011886 peripheral blood Substances 0.000 claims 1
- 229960005205 prednisolone Drugs 0.000 claims 1
- 230000035755 proliferation Effects 0.000 claims 1
- 210000001519 tissues Anatomy 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2003105379/14A RU2243784C2 (en) | 2003-02-25 | 2003-02-25 | Method for treatment of patients with chronic hepatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2003105379/14A RU2243784C2 (en) | 2003-02-25 | 2003-02-25 | Method for treatment of patients with chronic hepatitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2003105379A true RU2003105379A (en) | 2004-09-20 |
| RU2243784C2 RU2243784C2 (en) | 2005-01-10 |
Family
ID=34880918
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2003105379/14A RU2243784C2 (en) | 2003-02-25 | 2003-02-25 | Method for treatment of patients with chronic hepatitis |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2243784C2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2007137044A (en) * | 2007-10-05 | 2009-04-10 | Общество С Ограниченной Ответственностью "Концерн О3" (Ru) | HEMOPOESITIMULATING AND HEPATOPROTECTIVE ACTION MEDICINES |
| RU2614691C2 (en) * | 2015-07-14 | 2017-03-28 | Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") | Hepatoprotective substance |
-
2003
- 2003-02-25 RU RU2003105379/14A patent/RU2243784C2/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Vadhan-Raj | Management of chemotherapy-induced thrombocytopenia: current status of thrombopoietic agents | |
| Fang et al. | Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease | |
| Fang et al. | Human adipose tissue‐derived mesenchymal stromal cells as salvage therapy for treatment of severe refractory acute graft‐vs.‐host disease in two children | |
| Solders et al. | Effects of combined pancreatic and renal transplantation on diabetic neuropathy: a two-year follow-up study | |
| Theiss et al. | Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis | |
| US9301979B2 (en) | Method for attenuating immune response using mesenchymal stem cells and cytokines | |
| Wu et al. | Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation | |
| Sykes et al. | In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment. | |
| JP2016204396A5 (en) | ||
| US5196195A (en) | Use of arginase to control nitric oxide formation | |
| JP2004524278A5 (en) | ||
| RU2009107030A (en) | COMBINED THERAPY | |
| RU2013110491A (en) | USE OF ACID LYSOSOMIC LIPASE FOR TREATMENT OF ACID LYSOSOMIC LIPASE IN PATIENTS | |
| JP2005504018A5 (en) | ||
| CA2526244C (en) | Pharmaceutical combination of g-csf and plgf useful for blood stem cell mobilization | |
| RU2003105379A (en) | METHOD FOR TREATING PATIENTS WITH CHRONIC HEPATITIS | |
| Sylvestre | Approaching treatment for hepatitis C virus infection in substance users | |
| JP2016503070A5 (en) | ||
| RU2006107566A (en) | METHOD FOR TREATING VIRAL INFECTIONS | |
| MX2021013910A (en) | Methods of administering anti-cd38 antibody to treat multiple myeloma. | |
| Nishi et al. | Adipose tissue-derived mesenchymal stem cells ameliorate bone marrow aplasia related with graft-versus-host disease in experimental murine models | |
| Kasuga et al. | The role of cytotoxic macrophages in non-obese diabetic mice: cytotoxicity against murine mastocytoma and beta-cell lines | |
| JP2005529152A5 (en) | ||
| Lefrère et al. | Successful peripheral blood stem cell harvesting with granulocyte colony-stimulating factor alone after previous mobilization failure | |
| Sun et al. | Preventive effects of AHCC on carbon tetrachloride induced liver injury in mice |